Abstract
An attempt was made to achieve earlier detection of busulphan lung (fibrosing alveolitis) and to determine its incidence by means of serial studies during life, including measurement of the gas transfer factor. Twenty-three patients were investigated over an average period of nearly two years of busulphan treatment. One case of busulphan lung was detected and subsequently confirmed at necropsy, but in the remainder there was no clinical, radiological, or physiological evidence of fibrosing alveolitis. It is concluded that the development of fibrosing alveolitis may be related to individual genetic or immunological factors rather than to busulphan dosage.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Burns W. A., McFarland W., Matthews M. J. Busulfan-induced pulmonary disease. Report of a case and review of the literature. Am Rev Respir Dis. 1970 Mar;101(3):408–413. doi: 10.1164/arrd.1970.101.3.408. [DOI] [PubMed] [Google Scholar]
- Cotes J. E., Dabbs J. M., McDonald A., Davies S. E., Hall A. M. Transfer factor in asthma. Lancet. 1970 Mar 21;1(7647):626–627. doi: 10.1016/s0140-6736(70)91677-6. [DOI] [PubMed] [Google Scholar]
- Heard B. E., Cooke R. A. Busulphan lung. Thorax. 1968 Mar;23(2):187–193. doi: 10.1136/thx.23.2.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KYLE R. A., SCHWARTZ R. S., OLINER H. L., DAMESHEK W. A syndrome resembling adrenal cortical insufficiency associated with long term busulfan (myleran) therapy. Blood. 1961 Nov;18:497–510. [PubMed] [Google Scholar]
- LEAKE E., SMITH W. G. DIFFUSE INTERSTITIAL PULMONARY FIBROSIS AFTER BUSULPHAN THERAPY. Lancet. 1963 Aug 31;2(7305):432–434. doi: 10.1016/s0140-6736(63)92173-1. [DOI] [PubMed] [Google Scholar]
- Littler W. A., Kay J. M., Hasleton P. S., Heath D. Busulphan lung. Thorax. 1969 Nov;24(6):639–655. doi: 10.1136/thx.24.6.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
- OLINER H., SCHWARTZ R., RUBIO F., DAMESHEK W. Interstitial pulmonary fibrosis following busulfan therapy. Am J Med. 1961 Jul;31:134–139. doi: 10.1016/0002-9343(61)90229-7. [DOI] [PubMed] [Google Scholar]
- Smalley R. V., Wall R. L. Two cases of busulfan toxicity. Ann Intern Med. 1966 Jan;64(1):154–164. doi: 10.7326/0003-4819-64-1-154. [DOI] [PubMed] [Google Scholar]
- Ward H. N., Konikov N., Reinhard E. H. Cytologic dysplasia occurring after busulfan (Myleran) therapy. A syndrome resembling adrenocortical insufficiency and atrophic bronchitis. Ann Intern Med. 1965 Oct;63(4):654–660. doi: 10.7326/0003-4819-63-4-654. [DOI] [PubMed] [Google Scholar]
- Weatherall D. J., Galton D. A., Kay H. E. Busulphan and bone marrow depression. Br Med J. 1969 Mar 8;1(5644):638–638. doi: 10.1136/bmj.1.5644.638-a. [DOI] [PMC free article] [PubMed] [Google Scholar]